Elsevier

Life Sciences

Volume 57, Issue 22, 20 October 1995, Pages 2049-2055
Life Sciences

Expression of constitutive endothelial nitric oxide synthase in human blood platelets

https://doi.org/10.1016/0024-3205(95)02191-KGet rights and content

Abstract

Nitric oxide (NO) activates the soluble isoform of guanylate cyclase in platelets and inhibits platelet function. Several studies suggest the existence of a pathway for NO synthesis in platelets as a form of feedback inhibition, but the identity of the NO synthase (NOS) isoform present within platelets is unknown. We isolated human platelets and synthesized cDNA from platelet RNA for analysis by PCR. Primers for human neuronal or inducible NOS failed to yield a PCR signal. However, primers specific for endothelial NOS (ecNOS) amplified a DNA band of the expected size. Analysis of nucleotide sequence revealed that the amplified DNA is ecNOS. NOS enzyme activity was detected in the platelet particulate subcellular fraction, as previously demonstrated for ecNOS in other cells. Thus, ecNOS is present in human platelets and may play a role in the regulation of platelet function by an endogenous NO pathway.

References (39)

  • B.T. Mellion et al.

    Blood

    (1981)
  • M.W. Radomski et al.

    Lancet

    (1987)
  • T.M. Chiang et al.

    J. Biol. Chem.

    (1975)
  • A.J. Barber

    Biochim. Biophys. Acta

    (1976)
  • D.S. Houston et al.

    Biochim. Biophys. Acta

    (1983)
  • T. Malinski et al.

    Biochem. Biophys. Res. Comm.

    (1993)
  • R. Polanowska-Grabowska et al.

    Blood

    (1994)
  • P. Chomczynski et al.

    Anal. Biochem.

    (1987)
  • P.A. Marsden et al.

    FEBS Lett.

    (1992)
  • S.P. Janssens et al.

    J. Biol. Chem.

    (1992)
  • C. Nathan et al.

    J. Biol. Chem.

    (1994)
  • J.-L. Balligand et al.

    J. Biol. Chem

    (1995)
  • L. Busconi et al.

    J. Biol. Chem.

    (1994)
  • L.J. Robinson et al.

    J. Biol. Chem.

    (1995)
  • V. Mollace et al.

    Thromb. Res.

    (1991)
  • M. Noris et al.

    Kidney Internat.

    (1993)
  • J.R. Hampton et al.

    Cardiovascular Res.

    (1967)
  • J. Loscalzo

    J. Clin. Invest.

    (1985)
  • R.F. Furchgott et al.

    FASEB J.

    (1989)
  • Cited by (171)

    • Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure

      2022, Biochemical Pharmacology
      Citation Excerpt :

      Endothelial specific eNOS-KO Several laboratories including our group reported the role of non-endothelial eNOS in blood pressure homeostasis [192–194]. Non-endothelial eNOS expression was suggested in circulating blood cells including leucocytes[195], platelets [196] and RBCs [194], in the kidney [192] and in astrocytes of the brain stem[197]. The relative importance of endothelium-derived NO for the regulation of blood pressure was questioned in a study in which the bovine eNOS was endothelium-specifically re-expressed in the eNOS-KO mice [193].

    • Nitric oxide-enhancing or -releasing agents as antithrombotic drugs

      2019, Biochemical Pharmacology
      Citation Excerpt :

      cGMP, in turn, activates cGMP-dependent protein kinase G which phosphorylates several intracellular proteins which lower cytoplasmic calcium, favouring its reuptake by intracellular stores, its extrusion and inhibiting its influx, thus turning-off cell activation. Besides the endothelium, which probably generates the largest amount of NO in the circulation, also leukocytes, red blood cells and platelets express eNOS and iNOS [13–16]. eNOS-derived NO plays a pivotal role in the control of vascular tone and in the prevention of thrombosis and atherosclerosis [17], with differential roles played by the various cells.

    • Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases

      2017, Nitric Oxide - Biology and Chemistry
      Citation Excerpt :

      Altogether, these findings highlight the idea that accumulated nitrite correspond to an important NO reservoir. Although NOS3 was firstly described in endothelial cells [44,45], it is expressed in non-endothelial cell types including platelets [46], cardiomyocytes [47], and neurons [48]. In this regard, NOS3 expression and activity are regulated by transcriptional, posttranscriptional, and posttranslational mechanisms.

    • NOS, NO, and the Red Cell

      2017, Nitric Oxide: Biology and Pathobiology: Third Edition
    View all citing articles on Scopus
    View full text